Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples